Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.

Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS; MRC SUPREMO trial UK investigators.

Lancet Oncol. 2018 Nov;19(11):1516-1529. doi: 10.1016/S1470-2045(18)30515-1. Epub 2018 Oct 15. Erratum in: Lancet Oncol. 2018 Dec;19(12):e668.

2.

Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK.

Loncaster J, Armstrong A, Howell S, Wilson G, Welch R, Chittalia A, Valentine WJ, Bundred NJ.

Eur J Surg Oncol. 2017 May;43(5):931-937. doi: 10.1016/j.ejso.2016.12.010. Epub 2017 Jan 9. Erratum in: Eur J Surg Oncol. 2017 Nov 23;:.

3.

Tumour bed clip localisation for targeted breast radiotherapy: compliance is proportional to trial-related research activity: tumour bed clip localisation in breast radiotherapy.

Kirwan CC, Al Sarakbi W, Loncaster J, Chan HY, Thompson AM, Wishart GC.

Eur J Surg Oncol. 2014 Feb;40(2):158-62. doi: 10.1016/j.ejso.2013.11.016. Epub 2013 Dec 14.

PMID:
24373297
4.

Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas.

Loncaster J, Swindell R, Slevin F, Sheridan L, Allan D, Allan E.

Clin Oncol (R Coll Radiol). 2009 Aug;21(6):502-8. doi: 10.1016/j.clon.2009.03.004. Epub 2009 Apr 23.

PMID:
19398312
5.

Inter-fraction motion and dosimetric consequences during breast intensity-modulated radiotherapy (IMRT).

Jain P, Marchant T, Green M, Watkins G, Davies J, McCarthy C, Loncaster J, Stewart A, Magee B, Moore C, Price P.

Radiother Oncol. 2009 Jan;90(1):93-8. doi: 10.1016/j.radonc.2008.10.010. Epub 2008 Nov 13.

PMID:
19012980
6.

Hand function after high dose rate brachytherapy for squamous cell carcinoma of the skin of the hand.

Somanchi BV, Stanton A, Webb M, Loncaster J, Allan E, Muir LT.

Clin Oncol (R Coll Radiol). 2008 Nov;20(9):691-7. doi: 10.1016/j.clon.2008.06.008. Epub 2008 Aug 8.

PMID:
18693093
7.

A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre.

Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C.

Support Care Cancer. 2008 Feb;16(2):201-8. Epub 2007 Oct 10.

PMID:
17926070
8.

Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.

Madan V, Loncaster JA, Allan D, Lear JT, Sheridan L, Leach C, Allan E.

J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S86-9. Epub 2006 Aug 28.

PMID:
17052541
9.

The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.

Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Gebski V, West C, Lindegaard JC, Havsteen H, Davidson SE, Hunter R, Raleigh JA, Overgaard J.

Radiother Oncol. 2006 Aug;80(2):123-31. Epub 2006 Aug 4.

PMID:
16890316
10.

Photodynamic therapy in the management of a patient with Gorlin syndrome (naevoid basal cell carcinoma syndrome).

Loncaster JA, Allan E.

Photodiagnosis Photodyn Ther. 2006 Jun;3(2):134-7. doi: 10.1016/j.pdpdt.2006.03.011. Epub 2006 May 19.

PMID:
25049106
11.

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix.

Kabuubi P, Loncaster JA, Davidson SE, Hunter RD, Kobylecki C, Stratford IJ, West CM.

Br J Cancer. 2006 Jan 16;94(1):115-20.

12.

Extramammary Paget's disease treated with topical and systemic photodynamic therapy.

Madan V, Loncaster J, Allan D, Lear J, Sheridan L, Leach C, Allan E.

Photodiagnosis Photodyn Ther. 2005 Dec;2(4):309-11. doi: 10.1016/S1572-1000(05)00100-6. Epub 2005 Nov 11.

PMID:
25048872
13.

Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome-A pilot study.

Madan V, Loncaster J, Allan D, Lear J, Sheridan L, Leach C, Allan E.

Photodiagnosis Photodyn Ther. 2005 Dec;2(4):273-81. doi: 10.1016/S1572-1000(05)00101-8. Epub 2005 Nov 18.

PMID:
25048869
14.

An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy.

Loncaster JA, Moore JV, Allan D, Allan E.

Photodiagnosis Photodyn Ther. 2005 Jun;2(2):149-55. doi: 10.1016/S1572-1000(05)00064-5. Epub 2005 Aug 3.

PMID:
25048674
15.

The oligometastatic state in breast cancer: hypothesis or reality.

Tait CR, Waterworth A, Loncaster J, Horgan K, Dodwell D.

Breast. 2005 Apr;14(2):87-93. Review.

PMID:
15767177
16.

Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.

Hutchison GJ, Valentine HR, Loncaster JA, Davidson SE, Hunter RD, Roberts SA, Harris AL, Stratford IJ, Price PM, West CM.

Clin Cancer Res. 2004 Dec 15;10(24):8405-12.

17.

Adjuvant radiotherapy after conservative surgery for breast cancer: is it always necessary?

Loncaster J, Dodwell D.

Clin Oncol (R Coll Radiol). 2003 May;15(3):139-43. Review.

PMID:
12801053
18.

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.

Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Ladekarl M, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.

Radiother Oncol. 2003 Apr;67(1):35-44.

PMID:
12758238
19.

GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.

Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ.

Int J Cancer. 2003 Mar 10;104(1):85-91.

20.

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, Buckley DL, Davidson SE, Logue JP, Hunter RD, West CM.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):759-67.

PMID:
12377328
22.

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.

Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM.

Cancer Res. 2001 Sep 1;61(17):6394-9.

23.

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C.

Clin Cancer Res. 2001 Apr;7(4):928-34.

24.

Tumor vascularity: a histological measure of angiogenesis and hypoxia.

West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M.

Cancer Res. 2001 Apr 1;61(7):2907-10.

25.

Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.

Nordsmark M, Loncaster J, Chou SC, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):581-6.

PMID:
11173158
26.

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, West CM.

Radiother Oncol. 2000 Oct;57(1):53-9.

PMID:
11033189
27.

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.

Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM.

Br J Cancer. 2000 Sep;83(5):620-5.

Supplemental Content

Loading ...
Support Center